Garry Nolan Ph.D., Director at Akoya Biosciences, Inc. (AKYA), sold 46,182 shares at $13.31 ($615K) on 2022-09-09, disclosed to the SEC on 2022-09-13.
Open-market sale of $615k AKYA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.31 | 22,191 | $295K | 48.1% |
| 2 | $13.31 | 22,191 | $295K | 48.1% |
| 3 | $13.30 | 1,800 | $24K | 3.9% |
| Total | $13.31 avg | 46,182 | $615K | 100% |
| Filing → |
| AKYA | SELL | 2022-12-06 | $15K | — | Filing → |
| AKYA | SELL | 2022-12-02 | $67K | — | Filing → |
| AKYA | SELL | 2022-11-17 | $4K | — | Filing → |